Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T W J Huizinga

Showing results (11-20 of 234) with videos related to

Pageof 24
Sort By:
Scandinavian Journal of Rheumatology|April 17, 2008
Hyperpigmentation of the skin due to hydroxychloroquineM J Rood, M H Vermeer, T W J Huizinga
Clinical and Experimental Rheumatology|October 17, 2013
The BeSt way of withdrawing biologic agentsC F Allaart, W F Lems, T W J Huizinga
Rheumatology (Oxford, England)|November 30, 2007
Recent insights in the pharmacological actions of methotrexate in the treatment of rheumatoid arthritisJ A M Wessels, T W J Huizinga, H-J Guchelaar
Annals of the Rheumatic Diseases|May 15, 2012
The 2010 ACR/EULAR criteria for rheumatoid arthritis: do they affect the classification or diagnosis of rheumatoid arthritis?Annette H M van der Helm-van Mil, T W J Huizinga
RMD Open|May 14, 2016
Efficacy of etanercept in combination with methotrexate in moderate-to-severe rheumatoid arthritis is not dependent on methotrexate dosageG Gallo, F Brock, U Kerkmann, et al.
Clinical Rheumatology|January 29, 2014
Drug-free holiday in patients with rheumatoid arthritis: a qualitative study to explore patients' opinionI M Markusse, G Akdemir, T W J Huizinga, et al.
Seminars in Immunopathology|April 29, 2017
The role of autoantibodies in the pathophysiology of rheumatoid arthritisV F A M Derksen, T W J Huizinga, D van der Woude
The Netherlands Journal of Medicine|November 6, 2012
New biomarkers in rheumatoid arthritisA Willemze, R E M Toes, T W J Huizinga, et al.
Rheumatology (Oxford, England)|July 21, 2005
RUNX1 intronic SNP is not associated with rheumatoid arthritis susceptibility in Dutch CaucasiansJ Wesoly, R E M Toes, P E Slagboom, et al.
Rheumatology (Oxford, England)|August 12, 2004
Efficacy of UVA-1 cold light as an adjuvant therapy for systemic lupus erythematosusM C A Polderman, S le Cessie, T W J Huizinga, et al.
Pageof 24

Showing results (11-20 of 234) with videos related to

Sort By:
Pageof 24
Scandinavian Journal of Rheumatology|April 17, 2008
Hyperpigmentation of the skin due to hydroxychloroquineM J Rood, M H Vermeer, T W J Huizinga
Clinical and Experimental Rheumatology|October 17, 2013
The BeSt way of withdrawing biologic agentsC F Allaart, W F Lems, T W J Huizinga
Rheumatology (Oxford, England)|November 30, 2007
Recent insights in the pharmacological actions of methotrexate in the treatment of rheumatoid arthritisJ A M Wessels, T W J Huizinga, H-J Guchelaar
Annals of the Rheumatic Diseases|May 15, 2012
The 2010 ACR/EULAR criteria for rheumatoid arthritis: do they affect the classification or diagnosis of rheumatoid arthritis?Annette H M van der Helm-van Mil, T W J Huizinga
RMD Open|May 14, 2016
Efficacy of etanercept in combination with methotrexate in moderate-to-severe rheumatoid arthritis is not dependent on methotrexate dosageG Gallo, F Brock, U Kerkmann, et al.
Clinical Rheumatology|January 29, 2014
Drug-free holiday in patients with rheumatoid arthritis: a qualitative study to explore patients' opinionI M Markusse, G Akdemir, T W J Huizinga, et al.
Seminars in Immunopathology|April 29, 2017
The role of autoantibodies in the pathophysiology of rheumatoid arthritisV F A M Derksen, T W J Huizinga, D van der Woude
The Netherlands Journal of Medicine|November 6, 2012
New biomarkers in rheumatoid arthritisA Willemze, R E M Toes, T W J Huizinga, et al.
Rheumatology (Oxford, England)|July 21, 2005
RUNX1 intronic SNP is not associated with rheumatoid arthritis susceptibility in Dutch CaucasiansJ Wesoly, R E M Toes, P E Slagboom, et al.
Rheumatology (Oxford, England)|August 12, 2004
Efficacy of UVA-1 cold light as an adjuvant therapy for systemic lupus erythematosusM C A Polderman, S le Cessie, T W J Huizinga, et al.
Pageof 24